Personalized Cardiac Arrhythmia Treatment in New Applications

The inventive concept extends the core technology of personalized atrial fibrillation ablation to novel industries and use cases, including livestock health monitoring, high-performance athlete care, pet cardiac arrhythmia treatment, personalized cardiac rehabilitation, and remote monitoring.

The original patent disclosed a personalized atrial fibrillation ablation device for human cardiac arrhythmias. However, the limitations of this technology include its focus on human atrial fibrillation, neglecting the potential benefits for other species and applications. This inventive concept addresses these limitations by adapting the core technology to new industries and use cases, providing a more comprehensive approach to cardiac arrhythmia treatment.

The inventive concept comprises a system and method for applying the personalized atrial fibrillation ablation technology to various new applications. For instance, Claim 1 describes a system for personalized livestock health monitoring, utilizing a three-dimensional model of a livestock's heart to produce a customized ablation catheter for treating cardiac arrhythmias in livestock. Similarly, Claim 2 outlines a method for predicting and preventing cardiac arrhythmias in high-performance athletes using a personalized atrial fibrillation ablation device. The inventive concept also encompasses a personalized cardiac arrhythmia treatment system for pets, a personalized cardiac rehabilitation program, and a system for remote monitoring and personalized treatment of cardiac arrhythmias.

The inventive concept introduces novel applications and use cases for the personalized atrial fibrillation ablation technology, which are not obvious from the original patent. The new claims demonstrate a non-obvious extension of the core technology to new industries and problems, thereby providing a significant inventive step.

Alternative embodiments of the inventive concept could include adapting the technology to other species, such as equine or canine cardiac arrhythmia treatment. Variations may also involve integrating the personalized atrial fibrillation ablation technology with other medical devices, such as pacemakers or implantable cardioverter-defibrillators.

The inventive concept has significant commercial potential in various industries, including veterinary care, sports medicine, and remote healthcare monitoring. The target market includes companies and organizations involved in these industries, as well as research institutions and hospitals.